PF-219061

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C13H19NO2
Molecular Weight	221.2955
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PF-219061

Structure Search

SMILES

CCCN1CCO[C@@H](C1)C2=CC=CC(O)=C2

InChI

InChIKey=WYEGTIGJSHGEID-ZDUSSCGKSA-N

InChI=1S/C13H19NO2/c1-2-6-14-7-8-16-13(10-14)11-4-3-5-12(15)9-11/h3-5,9,13,15H,2,6-8,10H2,1H3/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C13H19NO2
Molecular Weight	221.2955
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Dopamine D3 receptor 91 Target ID: CHEMBL234 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17976986	Agonist 2678		27.0 nM [EC50]

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:11:54 GMT 2023` Edited by `admin` on `Sat Dec 16 16:11:54 GMT 2023`
Record UNII	ZK5ZP8L5S2
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PF-219061

Common Name

English

(R)-3-(4-PROPYLMORPHOLIN-2-YL) PHENOL

Common Name

English

PHENOL, 3-((2R)-4-PROPYL-2-MORPHOLINYL)-

Common Name

English

PF-219,061

Code

English

3-((2R)-4-PROPYLMORPHOLIN-2-YL)PHENOL

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID90430791

Created by admin on Sat Dec 16 16:11:54 GMT 2023 , Edited by admin on Sat Dec 16 16:11:54 GMT 2023

PRIMARY

FDA UNII

ZK5ZP8L5S2

Created by admin on Sat Dec 16 16:11:54 GMT 2023 , Edited by admin on Sat Dec 16 16:11:54 GMT 2023

PRIMARY

CAS

547770-05-8

Created by admin on Sat Dec 16 16:11:54 GMT 2023 , Edited by admin on Sat Dec 16 16:11:54 GMT 2023

PRIMARY

PUBCHEM

9794475

Created by admin on Sat Dec 16 16:11:54 GMT 2023 , Edited by admin on Sat Dec 16 16:11:54 GMT 2023

PRIMARY

WIKIPEDIA

PF-219,061

Created by admin on Sat Dec 16 16:11:54 GMT 2023 , Edited by admin on Sat Dec 16 16:11:54 GMT 2023

PRIMARY

Related Record Type Details


					G9XQ9S7T2F

D(3) DOPAMINE RECEPTOR

TARGET -> AGONIST

Comments:

A potent and highly selective agonist for the dopamine D3 receptor.

Qualification:

EC50

Amount:

Related Record Type Details


					ZK5ZP8L5S2

PF-219061

ACTIVE MOIETY

Comments:

It was under development as a potential medication for the treatment of female sexual dysfunction.

Amount: